Recent Blog Articles
Postpartum anxiety is invisible, but common and treatable
The popularity of microdosing of psychedelics: What does the science say?
Pouring from an empty cup? Three ways to refill emotionally
Is pregnancy safe for everyone?
New pediatric guidelines on obesity in children and teens
Screening tests may save lives — so when is it time to stop?
Natural disasters strike everywhere: Ways to help protect your health
The case of the bad placebo
Do we feel pain more at night?
If you use cannabis, do it safely
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Cancer
Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer
Men's Health
Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer
Cancer
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Men's Health
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Cancer
New imaging technique may help some men avoid prostate biopsy
Men's Health
New imaging technique may help some men avoid prostate biopsy
Cancer
Immediate radiation when PSA levels spike after prostate cancer surgery helps reduce risk of recurrence
Men's Health
New study recommends immediate radiation when PSA Levels spike after prostate cancer surgery
Cancer
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Men's Health
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Cancer
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Men's Health
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
New urine test predicts high-grade prostate cancer
Charlie Schmidt
New urine test predicts high-grade cancer
Cancer
The risks of active surveillance for men with intermediate-risk prostate cancers
Men's Health
Risks of active surveillance for men with intermediate-risk prostate cancers
Cancer
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Men's Health
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Men's Health
Promising results for a targeted drug in advanced prostate cancer
Cancer
Promising results for a targeted drug in advanced prostate cancer
Charlie Schmidt
Does fewer PSA tests mean less prostate cancer?
Cancer
Does fewer PSA tests mean less prostate cancer?
Cancer
Active surveillance is safe for low-risk prostate cancers
Cancer
